Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 6Active not recruiting 2Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 3Liver Neoplasms 2Klatskin Tumor 2Carcinoma, Hepatocellular 2Neuroendocrine Tumors 1Neoplasms 1Liver Diseases 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Colorectal Liver Metastases 1Colonic Neoplasms 1Cholangitis, Sclerosing 1Cholangiocarcinoma 1

Interventions

Fluorouracil 80Oxaliplatin 72Leucovorin 66Irinotecan 60Capecitabine 58Bevacizumab 57Cetuximab 43Folfox protocol 22Drug Therapy 22Neoadjuvant Therapy 19HMPL-013 17Colonoscopy 17regorafenib 15apatinib 11Panitumumab 11Chemotherapy, Adjuvant 11trifluridine tipiracil drug combination 10XELOX 10Laparoscopy 10IFL protocol 10sintilimab 9raltitrexed 9Radiotherapy 9Blood Specimen Collection 9Surveys and Questionnaires 8Surgical Procedures, Operative 8tislelizumab 7pembrolizumab 7Endoscopic Mucosal Resection 7Aspirin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colorectal Neoplasms × Liver Transplantation × Clear all
NCT03803436 2023-03-16

COLT

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
22 enrolled
Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡